Literature DB >> 2901360

Long-term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: an electrophysiological study in the rat.

A Bouthillier1, C De Montigny.   

Abstract

Acute benzodiazepine administration has been reported to antagonize the effect of cholecystokinin both in the periphery and in the central nervous system. A two-week treatment with either diazepam (5 mg/kg per day) or flurazepam (15 mg/kg per day) markedly reduced the excitatory effect of microiontophoretically applied sulphated cholecystokinin octapeptide-(26-33) on rat CA3 hippocampal pyramidal neurons but not that of acetylcholine. In view of the sustained anxiolytic activity of benzodiazepines that contrasts with their transient sedative effect, the present results suggest that the reduction of neuronal responsiveness to cholecystokinin by these drugs might be related to their anxiolytic property.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901360     DOI: 10.1016/0014-2999(88)90703-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988.

Authors:  L Singh; M J Field; C A Vass; J Hughes; G N Woodruff
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment.

Authors:  J Harro; M Põld; E Vasar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990 Jan-Feb       Impact factor: 3.000

3.  The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.

Authors:  P Chopin; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Dose ranging study of the effects of cholecystokinin in healthy volunteers.

Authors:  J Bradwejn; D Koszycki; M Bourin
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

5.  Effects of flumazenil on cholecystokinin-tetrapeptide-induced panic symptoms in healthy volunteers.

Authors:  J Bradwejn; D Koszycki; A Couëtoux du Tertre; M Paradis; M Bourin
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

6.  Benzodiazepine/cholecystokinin interactions at functional CCK receptors in rat brain.

Authors:  P R Boden; G N Woodruff
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.